SAMPAOLESI, MAURILIO
 Distribuzione geografica
Continente #
NA - Nord America 7.239
AS - Asia 5.637
EU - Europa 4.285
SA - Sud America 790
AF - Africa 186
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.160
Nazione #
US - Stati Uniti d'America 7.105
CN - Cina 2.823
SG - Singapore 1.225
IE - Irlanda 1.009
UA - Ucraina 618
BR - Brasile 600
HK - Hong Kong 585
FI - Finlandia 494
VN - Vietnam 478
DE - Germania 472
RU - Federazione Russa 411
IT - Italia 285
FR - Francia 277
GB - Regno Unito 243
SE - Svezia 209
IN - India 132
BE - Belgio 94
ZA - Sudafrica 91
BD - Bangladesh 69
CA - Canada 66
AR - Argentina 60
MX - Messico 48
IQ - Iraq 45
TR - Turchia 44
EC - Ecuador 39
NL - Olanda 36
PL - Polonia 31
ID - Indonesia 29
JP - Giappone 24
VE - Venezuela 24
PK - Pakistan 23
ES - Italia 22
UZ - Uzbekistan 21
SA - Arabia Saudita 18
KE - Kenya 16
TN - Tunisia 16
CO - Colombia 15
MA - Marocco 15
EG - Egitto 14
PY - Paraguay 14
AU - Australia 13
CL - Cile 13
CZ - Repubblica Ceca 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
MY - Malesia 11
PH - Filippine 11
PE - Perù 10
DZ - Algeria 9
IR - Iran 9
LT - Lituania 9
AT - Austria 8
AZ - Azerbaigian 8
EU - Europa 8
CH - Svizzera 7
KZ - Kazakistan 7
UY - Uruguay 7
BO - Bolivia 5
EE - Estonia 5
KG - Kirghizistan 5
KR - Corea 5
RO - Romania 5
SN - Senegal 5
TH - Thailandia 5
ET - Etiopia 4
GR - Grecia 4
JM - Giamaica 4
LV - Lettonia 4
MU - Mauritius 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
LK - Sri Lanka 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
Totale 18.138
Città #
Dublin 1.009
Chandler 938
Jacksonville 786
San Jose 765
Nanjing 642
Ashburn 627
Singapore 625
Hong Kong 574
Dallas 413
Beijing 371
Boardman 339
Nanchang 270
Princeton 215
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 180
Lauterbourg 176
Ho Chi Minh City 174
Los Angeles 174
Changsha 163
Ann Arbor 157
Jiaxing 157
Helsinki 141
Hangzhou 110
Tianjin 106
Hanoi 102
Buffalo 92
Milan 87
Johannesburg 80
Munich 67
Shanghai 64
Moscow 63
Woodbridge 62
Redondo Beach 60
New York 56
Pavia 54
Verona 51
Council Bluffs 49
Orem 45
São Paulo 45
Brussels 41
Herent 33
Norwalk 31
Chennai 29
Seattle 29
Turku 29
Fairfield 26
Guangzhou 26
Santa Clara 26
Warsaw 26
Brooklyn 25
Frankfurt am Main 25
Toronto 24
Baghdad 23
Kunming 23
Pune 23
The Dalles 23
Da Nang 22
Montreal 22
Washington 21
Chicago 20
Des Moines 20
Falkenstein 20
Houston 20
Leuven 20
Tokyo 20
San Francisco 18
Tashkent 18
Amsterdam 16
Auburn Hills 15
Denver 15
Jinan 15
Mumbai 15
Nuremberg 15
Rio de Janeiro 15
Ankara 14
Brasília 14
Falls Church 14
London 14
Manchester 14
Nairobi 14
Phoenix 14
Poplar 14
Biên Hòa 13
Haiphong 13
Lahore 13
Mexico City 13
Quito 13
Stockholm 13
Zhengzhou 13
Belo Horizonte 12
Boston 12
Amman 11
Guayaquil 11
Ningbo 11
Redwood City 11
Atlanta 10
Caracas 10
Totale 11.975
Nome #
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 187
Electromagnetic fields influence the gene expression of SAOS-2 cell line 172
Evaluation of energy expenditure in athletes practising horseback riding 170
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 167
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 163
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 161
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 155
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 154
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 154
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 151
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 149
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 146
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 144
Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model 140
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 128
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 127
Adult Stem Cells and Skeletal Muscle Regeneration 126
Gene signature of muscle hypertrophy 126
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 125
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 124
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 124
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 121
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 121
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 121
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 119
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 119
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 119
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 118
Cell therapy strategies and improvements for muscular dystrophy. 117
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 115
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 114
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 114
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 113
Bedside to bench: a look at experimental research with a clinical trial checklist 112
Evaluation of the effects of a dynamic culture on osteogenic differentiation of oral-periosteal cells grown on PLGA sponges 111
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 110
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 110
In vitro and in vivo tissue engineering approaches in regenerative medicine 109
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 109
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 108
Aging affects the in vivo regenerative potential of human mesoangioblasts 108
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 107
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 107
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 106
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 106
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 105
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 105
Brief Communication Arising 103
Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells 103
The effects of micro-grafts in the treatment of androgenetic alopecia 103
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 102
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 101
About Mesoangioblasts 101
Alteration of cardiac progenitor cell potency in GRMD dogs 101
Guide cells support muscle regeneration and affect neuro-muscular junction organization 101
Magic-F1 transgene cooperates with Pax 3 during early myogenesis to induce muscular hypertrophy 100
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation 100
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 99
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 99
Inducing muscular hypertrophy by recombinant proteins 99
Poly-l-Lactic Acid Nanofiber–Polyamidoamine Hydrogel Composites: Preparation, Properties, and Preliminary Evaluation as Scaffolds for Human Pluripotent Stem Cell Culturing 99
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 99
Cardiac development and remodelling in Magic-F1 transgenic mice 99
In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly-L-lysine-treated titanium-6-aluminium-4-vanadium 96
Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery 96
Skeletal muscle engineering: scaffolds and recombinant proteins 96
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 95
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 95
Magic F-1: a new engineered protein involved in muscular hypertrophy and regeneration 95
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives 95
Muscle hypertrophy and vascularization induction using recombinant proteins 93
The investigation of the effects of autologous micrografts in the process of wound healing 93
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 92
Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. 92
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 91
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 91
New therapies for muscular dystrophy: cautious optimism. 91
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 90
Skeletal muscle regenerative approach combining stem cells and 3D bioprinting 90
Exploring wound-healing genomic machinery with a network-based approach 90
Terapia cellulare mesenchimale nella distrofia muscolare 89
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 88
Hamster cardiomyocytes: a model of myocardial regeneration? 88
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 88
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 87
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 87
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 87
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 87
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 87
Stem Cell homing and regulation: new insights from muscular dystrophy 86
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 86
Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo 86
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 85
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 85
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 85
Stem cell-niche and lysosomal cathepsins 85
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 85
Welcome to Cardiovascular Research in 2015 85
Mononucleated Cells to Regenerate Skeletal Muscle Syncytial Tissues 85
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells 84
Totale 10.932
Categoria #
all - tutte 77.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/2022860 19 6 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/20252.473 38 242 116 78 40 87 125 170 559 71 287 660
2025/20266.014 473 485 757 748 695 223 1.124 248 459 491 291 20
Totale 18.407